AA

Anjula Aggarwal

Active Director Director DIN 10081600
DIN 10081600 First appointment Mar 2023
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Mar 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Anjula Aggarwal

Data last updated:

Anjula Aggarwal is a Director at Puremedic Biotech Private Limited (since 2024) and Director at Yeoman Organics Private Limited (since 2023).

DIN 10081600
Primary Designation Director
First Appointment 20 Mar 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Puremedic Biotech Private Limited U46497HR2024PTC121632
Director16 May 20242024Active
Yeoman Organics Private Limited U46497HR2023PTC110073
Director20 Mar 20232023Active

Board colleagues of Anjula Aggarwal

Directorship timeline

Open interactive timeline →
Yeoman Organics Private Limited
Puremedic Biotech Private Limited
Premium access

Shareholding and investment profile for Anjula Aggarwal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anjula Aggarwal

Anjula Aggarwal currently holds 2 directorships: Puremedic Biotech Private Limited (Director, since 16 May 2024); Yeoman Organics Private Limited (Director, since 20 Mar 2023).

Anjula Aggarwal was first appointed on 20 Mar 2023 as Director at Yeoman Organics Private Limited. The most recent appointment on record is 16 May 2024 at Puremedic Biotech Private Limited.

The current boards of Anjula Aggarwal's companies include Naman Aggarwal (Puremedic Biotech Private Limited), Itisri Sahu (Yeoman Organics Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available